Thursday, 5 December 2013

High Impact Factor Journals of Bentham Science Publishers

Scholarly publishing renders a great service to science, research and academic literature. The industry is largely dominated by subscription-based publishing which has existed for as long as the scholarly journals publishing it (Paul Peters, 2007). Academic journals and the quality of the research published in them are judged by their impact factor, a measure of the number of citations to articles published in the journals.
Bentham Science is a rapidly growing scholarly journal publisher and has been serving the academia and libraries for the last 25 years. They publish 122 subscription based journals, while their flagship products include 32 journals with impact factors. Current Medicinal Chemistry has an impact factor of 4.07 and is considered to be one of the most popular peer-reviewed journals in its respective field. It publishes the latest research, new developments in the field of medicinal chemistry and drug. This is one of the most highly recommended journals in the field of medicinal chemistry.
Another name in the list of high impact factor journals from Bentham Science Publishers’ is  Current Cancer Drug Targets. The impact factor for this journal is 4.00. aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular drug targets involved in cancer, e.g. disease specific proteins, receptors, enzymes and genes. It publishes original research articles, latest reviews and clinical studies.
Current Molecular Medicine (Impact Factor: 4.197) covers the recent developments in the fundamental molecular mechanisms of disease pathogenesis, and the development of molecular-diagnosis and/or novel approaches to rational treatment.
For a complete list of Bentham Science Publishers’ High Impact Factor Journals, kindly log on to and


Post a Comment

    Blogger news